arrow
C

Christina Fournier

Emory University
H指数:21
被引数:2,387

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Primary Lateral Sclerosis Natural History Study: Primary Lateral Sclerosis Functional Rating Scale and Other Outcomes Assessment

原发性侧索硬化自然史研究:原发性侧索硬化功能评分量表及其他结局评估

2025-09-010
PRE
Molecular impact of antisense oligonucleotide therapy in C9orf72-associated ALS

C9orf72相关ALS中反义寡核苷酸疗法的分子影响

Cell
IF42.5
2025-08-260
OAAI
Network analysis of the cerebrospinal fluid proteome reveals shared and unique differences between sporadic and familial forms of amyotrophic lateral sclerosis

脑脊液蛋白质组网络分析揭示了散发性与家族性肌萎缩侧索硬化症之间的共享及独特差异

2025-05-150
OA
Risk prediction for ALS using semi-competing risk models with applications to the ALS Natural History Consortium dataset

使用半竞争风险模型对ALS进行风险预测及其在ALS自然病史联盟数据集中的应用

2025-05-140
PRE
Time-to-event prediction in ALS using a landmark modeling approach, using the ALS Natural History Consortium dataset

使用landmark建模方法在ALS中进行时间到事件预测,使用ALS Natural History Consortium数据集

2025-04-020
OA
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis, A Randomized Clinical Trial

Zilucoplan治疗肌萎缩侧索硬化症的疗效与安全性:一项随机临床试验

2025-02-173
OA
Results from the first four regimens of the HEALEY ALS Platform Trial
2023-04-250
PRE
Effect of sodium phenylbutyrate/taurursodiol on tracheostomy/ventilation-free survival and hospitalisation in amyotrophic lateral sclerosis: long-term results from the CENTAUR trial
2022-05-1651
OAAI
Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis
2020-09-03345
OAAI